88 related articles for article (PubMed ID: 2099403)
1. A further characterization of B-CLL lymphocytes: phenotypic and functional studies.
Merle-Béral H
Nouv Rev Fr Hematol (1978); 1990; 32(5):319-21. PubMed ID: 2099403
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of CD5 on in vitro activated human B cells.
Freedman AS; Freeman G; Whitman J; Segil J; Daley J; Levine H; Nadler LM
Eur J Immunol; 1989 May; 19(5):849-55. PubMed ID: 2472277
[TBL] [Abstract][Full Text] [Related]
3. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
Karray S; Emilie D; Galanaud P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
[TBL] [Abstract][Full Text] [Related]
5. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
6. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia.
Koníková E; Babusíková O; Mesárosová A; Kusenda J; Glasová M
Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317
[TBL] [Abstract][Full Text] [Related]
8. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
Sellitto A; De Fanis U; Romano C; Dalla Mora L; Guastafierro S; Tirelli A; Lucivero G
Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
10. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
Büssing A; Stein GM; Stumpf C; Schietzel M
Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
[TBL] [Abstract][Full Text] [Related]
11. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
[TBL] [Abstract][Full Text] [Related]
12. The nature of the B lymphocyte in B-chronic lymphocytic leukemia.
Caligaris-Cappio F; Gottardi D; Alfarano A; Stacchini A; Gregoretti MG; Ghia P; Bertero MT; Novarino A; Bergui L
Blood Cells; 1993; 19(3):601-13. PubMed ID: 7517220
[TBL] [Abstract][Full Text] [Related]
13. Immunobiology of chronic lymphocytic leukemia.
Freedman AS
Hematol Oncol Clin North Am; 1990 Apr; 4(2):405-29. PubMed ID: 2182599
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal expansion of immunoglobulin not-secreting CD5+ CD11c+ CD38+ B-cells in a rare case of chronic lymphoplasmacytoid leukaemia.
Grande M; Lucivero G; Gambatesa V; Schiraldi O; Bonomo L
Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):235-40. PubMed ID: 7971244
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
17. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
Engel P; Inglés J; de la Calle O; Gallart T
Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemia.
Nishii K; Katayama N; Mitani H; Matsumoto T; Miwa H; Kita K; Shiku H
Int J Hematol; 2000 Jan; 71(1):59-65. PubMed ID: 10729995
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
